SE8009157L - Sett att framstellning hogrenade koncentrat av protrombinkomplex, de erhallna koncentraten och framstellning derav - Google Patents

Sett att framstellning hogrenade koncentrat av protrombinkomplex, de erhallna koncentraten och framstellning derav

Info

Publication number
SE8009157L
SE8009157L SE8009157A SE8009157A SE8009157L SE 8009157 L SE8009157 L SE 8009157L SE 8009157 A SE8009157 A SE 8009157A SE 8009157 A SE8009157 A SE 8009157A SE 8009157 L SE8009157 L SE 8009157L
Authority
SE
Sweden
Prior art keywords
preparation
concentrate
prothrombinogenic
compound
elution
Prior art date
Application number
SE8009157A
Other languages
English (en)
Other versions
SE452250B (sv
SE452250C (sv
Inventor
M Chanas
J Liautaud
E Shanbrom
Original Assignee
Merieux Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merieux Inst filed Critical Merieux Inst
Publication of SE8009157L publication Critical patent/SE8009157L/sv
Publication of SE452250B publication Critical patent/SE452250B/sv
Publication of SE452250C publication Critical patent/SE452250C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8009157A 1979-05-04 1980-12-29 Sätt att framställa ett koncentrat av protrombinkomplex SE452250C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7911272A FR2472390A1 (fr) 1979-05-04 1979-05-04 Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
PCT/FR1980/000069 WO1980002426A1 (fr) 1979-05-04 1980-05-05 Concentres de complexe prothrombinique, preparation et application

Publications (3)

Publication Number Publication Date
SE8009157L true SE8009157L (sv) 1980-12-29
SE452250B SE452250B (sv) 1987-11-23
SE452250C SE452250C (sv) 1998-04-06

Family

ID=9225039

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8009157A SE452250C (sv) 1979-05-04 1980-12-29 Sätt att framställa ett koncentrat av protrombinkomplex

Country Status (18)

Country Link
US (1) US4465623A (sv)
JP (1) JPH0424360B2 (sv)
AR (1) AR227021A1 (sv)
AT (1) ATA903980A (sv)
BE (1) BE883096A (sv)
CA (1) CA1157375A (sv)
CH (1) CH654329A5 (sv)
DE (1) DE3043409C3 (sv)
DK (1) DK157169C (sv)
ES (1) ES8100763A1 (sv)
FR (1) FR2472390A1 (sv)
GB (1) GB2061287B (sv)
IT (1) IT1131109B (sv)
MX (1) MX5960E (sv)
NL (1) NL8020152A (sv)
NO (1) NO155477C (sv)
SE (1) SE452250C (sv)
WO (1) WO1980002426A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663164A (en) * 1980-01-28 1987-05-05 Baxter Travenol Laboratories, Inc. Aqueous compositions for treating blood clotting factor inhibitors
WO1981002105A1 (en) * 1980-01-28 1981-08-06 Baxter Travenol Lab Therapeutic compositions & methods for manufacture and use
AT379310B (de) * 1983-05-20 1985-12-27 Immuno Ag Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
DE3727610A1 (de) 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung
US6541275B1 (en) 1988-02-03 2003-04-01 Dade Behring Inc. Immunoassay for F1.2 prothrombin fragment
JPH0219400A (ja) * 1988-07-07 1990-01-23 Green Cross Corp:The トロンビンまたはプロトロンビンの製造方法
WO1994022471A1 (en) * 1993-04-05 1994-10-13 The Green Cross Corporation Liquid antithrombin iii preparation and method of stabilizing the same
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US20080306610A1 (en) * 2007-06-07 2008-12-11 Zimmer Orthobiologics, Inc. Tissue processing for nonimmunogenic implants
US8435305B2 (en) 2010-08-31 2013-05-07 Zimmer, Inc. Osteochondral graft delivery device and uses thereof
USD863685S1 (en) 2017-11-27 2019-10-15 Mary Kay Inc. Cosmetic compact
USD850006S1 (en) 2017-11-27 2019-05-28 Mary Kay Inc. Cosmetic compact
USD843660S1 (en) 2017-11-27 2019-03-19 Mary Kay Inc. Cosmetic compact

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
JPS5314604B2 (sv) * 1972-12-20 1978-05-18
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
US4081432A (en) * 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
JPS6040859B2 (ja) * 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"

Also Published As

Publication number Publication date
ES491042A0 (es) 1980-12-01
NO155477B (no) 1986-12-29
IT1131109B (it) 1986-06-18
DE3043409C2 (sv) 1993-12-23
CA1157375A (fr) 1983-11-22
US4465623A (en) 1984-08-14
NL8020152A (nl) 1981-02-27
WO1980002426A1 (fr) 1980-11-13
MX5960E (es) 1984-09-06
FR2472390A1 (fr) 1981-07-03
ATA903980A (de) 1982-05-15
JPH0424360B2 (sv) 1992-04-24
BE883096A (fr) 1980-11-03
GB2061287B (en) 1983-09-14
SE452250B (sv) 1987-11-23
DK157169B (da) 1989-11-20
DK157169C (da) 1990-04-23
DE3043409T1 (de) 1982-02-18
GB2061287A (en) 1981-05-13
DE3043409C3 (de) 1993-12-23
JPS56500569A (sv) 1981-04-30
SE452250C (sv) 1998-04-06
NO810009L (no) 1981-01-02
NO155477C (no) 1987-04-08
ES8100763A1 (es) 1980-12-01
AR227021A1 (es) 1982-09-15
FR2472390B1 (sv) 1983-07-08
DK1281A (da) 1981-01-02
IT8021723A0 (it) 1980-05-02
CH654329A5 (fr) 1986-02-14

Similar Documents

Publication Publication Date Title
SE8009157L (sv) Sett att framstellning hogrenade koncentrat av protrombinkomplex, de erhallna koncentraten och framstellning derav
HK121293A (en) Desulfatohirudine,process for its preparation and pharmaceutical agent
AU558711B2 (en) Enzyme preparation for treatment of liver and kidney disease
ES525361A0 (es) Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl.
DE3683586D1 (de) Behandlung des atemunwohlseinsyndroms bei erwachsenen.
DE3166201D1 (en) Process for the preparation of blood coagulation factors, and preparation containing factors ii and vii
DE3167338D1 (en) Stabilisation of factor viii activity in blood plasma
FI921009A0 (fi) Aemnen foer diagnostisering av neuropatier som foerorsakar myelinfoerlust.
ES494343A0 (es) Procedimiento de obtencion de un activador del plasminogeno
AU575296B2 (en) Agent for treatment of wounds
ES532641A0 (es) Procedimiento para la preparacion de un concentrado de antitrombina iii-heparina o de antitrombina iii-heparinoide
ES535409A0 (es) Procedimiento para pasterizar un plasma de radical-humano
MX167398B (es) Procedimiento para pasterizar plasma o concentrados de factores, ii, vii, ix y x de coagulacion de sangre
BG97199A (bg) Антикоагулантен препарат
JPS54164388A (en) Contrast blood plasma for anticoagulant treatment monitor
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
BG50904A1 (en) A process for different species origin cholinesterase preparation

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8009157-2

Format of ref document f/p: F